Donghong Xu
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 05, 2026
Clinical Evaluation of Drug-Drug Interactions With Aficamten.Neha Maharao, Donghong Xu, Punag Divanji
|Aug 23, 2025
Correction: Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten.Donghong Xu, Justin D Lutz, Punag Divanji
|Aug 18, 2025
Toward a Quantitative Understanding of Aficamten Clinical Pharmacology: Population Pharmacokinetic Modeling.Donghong Xu, Hanbin Li, Stephen B Heitner
|Apr 09, 2025
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants.Neha Maharao, Donghong Xu, Tyrell J Simkins
|Feb 05, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten.Donghong Xu, Justin D Lutz, Punag Divanji
|Sep 11, 2024
Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans.Donghong Xu, Punag Divanji, Adrienne Griffith
Pageof 1
